2023 Thermo Fisher Product Catalog now available
Products are for professional/laboratory use only.
We are pleased to launch the Thermo Fisher Phadia product catalog for ImmunoCAP and EliA.
Products are for professional/laboratory use only.
We are pleased to launch the Thermo Fisher Phadia product catalog for ImmunoCAP and EliA.
Products are for professional/laboratory use only. ImmunoCAP component from Thermo Fisher – Allergen Component rSes i 1 Sesame seed.
Phadia Prime is the operator software developed for the Phadia Laboratory Systems: Phadia™ 100, Phadia™ 200, Phadia™ 250, Phadia™ 1000, Phadia™ 2500 series and Phadia™ 5000 series of instrument.
Products are for professional/laboratory use only. ImmunoCAP™ Allergen f454, Allergen Component rPru p 7 Peach is now available for testing.
Explain the diagnostic gap observed in peach allergic patients
Products are for professional/laboratory use only.
White paper: The Serum Tryptase Test – Use in Clinical Hematology
Wolfgang R. Sperr & Peter Valent, Medicaly University of Vienna
Thermo Fisher Scientific ImmunoCAP range of allergy tests is the gold standard testing technology for specific IgE blood testing. As pioneers in allergy diagnostics Thermo Fisher Scientific have more than 50 years of experience in allergen production and specific IgE product development.
Products are for professional/laboratory use only. Asthma is a serious respiratory condition affecting both children and adults across Australia and New Zealand. Over 2.5 million (about 1 in 9) Australians have asthma with more children than adults affected. There are over 400 asthma deaths each year in Australia alone.1
The Phadia range of instruments: Phadia 200, Phadia 250, and Phadia 2500, are the only automated systems available that offer both ImmunoCAP Allergy and EliA Autoimmune testing on the one platform.
The Phadia range of instruments by Thermo Fisher: Phadia 200, Phadia 250, and Phadia 2500, are the only automated systems available that offer both ImmunoCAP Allergy and EliA Autoimmune testing on the one platform.